Dec 02, 2019 - Better-than-expected performance at CVI and CSI, and higher revenues are likely to have aided Cooper Companies (COO) in Q4 earnings.
Dec 03, 2019 -
Three Ann Arbor cannabis joints — just a few of the six Michigan retailers licensed to distribute recreational pot on Dec. 1 — raked in $221,000 in post-tax sales Sunday on the state’s first day of legal adult-use transactions.
Dec 03, 2019 -
Baltimore mayor Bernard Young expressed concern over a social media post he saw about a white van snatching young girls in order to harvest and sell their organs.
“We’re getting reports of somebody in a white van trying to snatch up young girls for human trafficking and for selling body parts,...
Dec 03, 2019 - CrowdStrike's (CRWD) third-quarter fiscal 2020 results are likely to reflect higher subscription revenues.
Dec 03, 2019 - Vail Resorts' (MTN) revenues in first-quarter fiscal 2020 are likely to reflect robust performance of the Mountain segment.
Dec 04, 2019 -
Aquaman just wants to protect the oceans.
Jason Mamoa apologized to Chris Pratt for calling him out in the comments of an Instagram post where he was holding a single-use plastic water bottle.
Pratt, 40, posted a sponsored Amazon ad for workout gear that he uses on Instagram Tuesday. In the picture,...
Dec 05, 2019 - Powell Industries (POWL +14.7%) reported Q4 revenue growth of 10.1% Y/Y to $148.5M, and orders totaled $168M (+107.7% Y/Y).Q4 gross margin improved by 143 bps to 19.2%; and operating margin improved b
Dec 05, 2019 - Secureworks up (SCWX +20.5%) as the company says that revenue, gross margin, adjusted EBITDA and cash flow were strong in Q3 and exceeded expectations.For Q4 2020, the Company expects revenue of $138M
Dec 05, 2019 - Gene therapy continues to draw attention with the recent spate of deals and acquisitions. We list four stocks with promising candidates in their pipelines that make attractive acquisition targets.
Dec 05, 2019 - Spero (SPRO) reports preliminary findings from a phase I first-in-human study on SPR720, presently being evaluated for the treatment of nontuberculous mycobacterial pulmonary disease.